TSO3 deal with Getinge may set stage for takeout, says Laurentian

TS03's low-temperature 125 litre STERIZONE® sterilizer is designed for terminal sterilization of heat and moisture sensitive medical devices.

A deal that will see Getinge become the exclusive agent for TSO3’s (TSX:TOS) core product heightens the possibility that the former may buy the latter, says Laurentian Bank Securities analyst Nick Agostino. Yesterday, TSO3 announced it had granted Getinge Infection Control AB the exclusive global rights to distribute its Sterizone VP4 sterilizer for (U.S.) $7.5-million, […]

Gene silencing could lead to cancer breakthrough, says Canadian study

human genome

Canadian scientists have used gene silencing to make what they hope could be a breakthrough in the treatment of cancer. Researchers from the University of Toronto, led by Molecular Genetics Professor Jason Moffat from the University of Toronto’s Donnelly Centre, published a study in the journal Cell yesterday that details how they switched off about […]

Canadian researchers eye breakthrough in the battle against deadly fungus

Micrograph of esophageal candidiasis showing hyphae, biopsy specimen, PAS stain.

New Canadian research may mean a breakthrough in the fight against a deadly fungus and could further our understanding of how microbial communities affect human health. The University of Toronto study, called “Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of […]

Facebook use may trigger depression in some teens, says Canadian study


A new Canadian study says some teens may be vulnerable to depression and mental illness later in life due to brain triggers from using social media. The study, led by University of Montreal professor Sonia Lupien and published in the journal Psychoneuroendocrinology looked at the behaviour of 88 participants between the ages of twelve and […]

Telesta Therapeutics gets price target slashed at Euro Pacific


Telesta Therapeutics (TSX:TST) received news today from the FDA that was a clear negative even if the reasoning behind it may be puzzling, says Euro Pacific Canada analyst Doug Loe. This morning, Telesta announced a negative result in its biologics licence application (BLA) for MCNA. The FDA voted 18 “no’s” to six “yes’s” to the […]

ProMetic’s deal with ProThera gets thumbs up at Paradigm

Prometic Life Sciences CEO Pierre Laurin.

Paradigm Capital analyst Christopher Lam likes the partnership ProMetic Life Sciences (TSX:PLI) signed today and expects similar deals will happen in the future. This morning, ProMetic announced it had entered into a strategic partnership with ProThera Biologics Inc. for the development and commercialization of human plasma-derived interalpha inhibitor proteins. “We are very pleased to be […]

Concordia Healthcare Q3 gets thumbs up at Cantor Fitzgerald Canada

Concordia Healthcare CEO Mark Thompson on BNN Wednesday, October 21.

A quarter from Concordia Healthcare (TSX:CXR, Nasdaq: CXRX) that met expectations is getting the thumbs up from Cantor Fitzgerald Canada analyst Scott Curtis. On November 12, Concordia Healthcare reported its third quarter, 2015 results. The company lost (U.S.) $4.39-million on revenue $94.9-million, a 161% topline bump over the same period last year. “Our legacy business […]

Parkinson’s disease: Canadian researchers may have made key breakthrough

Dr. Ron Postuma at the Renata Hornstein Parkinson's clinic of the McGill University Health Centre.

Canadian researchers may have made a major breakthrough is one of the world’s most misdiagnosed diseases, Parkinson’s. Scientists from McGill University Health Centre say they have developed a new list of criteria for the early diagnosis of Parkinson’s, which is frequently misdiagnosed because it so closely resembles other neurological disorders. Their study, published in the […]

Canadian-made blood pressure device that is worn on wrist gets clinical validation


A non-invasive, wrist-worn blood pressure monitor developed by Kitchener-based Cloud DX has been found to be comparably accurate to an intra-arterial blood pressure catheter by an independent clinical validation study carried out at the New Brunswick Heart Centre in Saint John. Cloud DX’s Pulsewave device was found to be within 5 to 10 mmHg of […]

Opsens getting support from key opinion leaders, says M Partners


Opsens (TSXV:OPS) is making real progress with its Optowire and OptoMonitor products, says M Partners analyst Daniel Pearlstein. Yesterday, Opsens announced that it had been granted granted CE marking for its pressure guide wire, OptoWire II, a device that was developed to measure fractional flow reserve in patients with coronary artery disease. The CE marking, […]